SNANF (Sona Nanotech) Cyclically Adjusted Book per Share: $0.00 (As of Jan. 2026)


SNANF Sona Nanotech Inc SNANF
26 GF Score
Price $0.32
! 1 Warning Sign
View Full Analysis

What is Sona Nanotech Cyclically Adjusted Book per Share?

Sona Nanotech SNANF 26 Cyclically Adjusted Book per Share is $0.00 as of Jan. 2026. GuruFocus rates SNANF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sona Nanotech's adjusted book value per share for the three months ended in Jan. 2026 was $-0.001. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Jan. 2026.

During the past 12 months, Sona Nanotech's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sona Nanotech was -21.90% per year. The lowest was -41.50% per year. And the median was -27.70% per year.

As of today (2026-07-03), Sona Nanotech's current stock price is $0.3154. Sona Nanotech's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2026 was $0.00. Sona Nanotech's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sona Nanotech was 85.28. The lowest was 0.00. And the median was 0.00.


Sona Nanotech  (OTCPK:SNANF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sona Nanotech was 85.28. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sona Nanotech Cyclically Adjusted Book per Share Related Terms


Sona Nanotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sona Nanotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sona Nanotech Cyclically Adjusted Book per Share Chart

Sona Nanotech Annual Data
Trend Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.02 0.02 0.01 0.00

Sona Nanotech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.00 0.00

SNANF vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Sona Nanotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Cyclically Adjusted PB Ratio falls into.


SNANF
26GF Score
Sona Nanotech Inc SNANF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sona Nanotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sona Nanotech's adjusted Book Value per Share data for the three months ended in Jan. 2026 was:

Adj_Book= Book Value per Share /CPI of Jan. 2026 (Change)*Current CPI (Jan. 2026)
=-0.001/130.3700*130.3700
=-0.001

Current CPI (Jan. 2026) = 130.3700.

Sona Nanotech Quarterly Data

Book Value per Share CPI Adj_Book
201601 0.046 100.184 0.060
201604 0.049 101.370 0.063
201607 0.025 101.844 0.032
201610 0.023 102.002 0.029
201701 0.022 102.318 0.028
201704 0.021 103.029 0.027
201707 0.026 103.029 0.033
201801 0.001 104.056 0.001
201804 -0.002 105.320 -0.002
201807 -0.003 106.110 -0.004
201810 0.003 105.952 0.004
201901 -0.002 105.557 -0.002
201904 -0.007 107.453 -0.008
201907 -0.010 108.243 -0.012
201910 -0.013 107.927 -0.016
202001 -0.010 108.085 -0.012
202004 -0.017 107.216 -0.021
202007 -0.026 108.401 -0.031
202010 -0.042 108.638 -0.050
202101 -0.022 109.192 -0.026
202104 -0.021 110.851 -0.025
202107 -0.014 112.431 -0.016
202110 -0.015 113.695 -0.017
202201 0.003 114.801 0.003
202204 -0.003 118.357 -0.003
202207 -0.006 120.964 -0.006
202210 -0.005 121.517 -0.005
202301 -0.009 121.596 -0.010
202304 0.019 123.571 0.020
202307 0.013 124.914 0.014
202310 0.009 125.310 0.009
202401 0.009 125.072 0.009
202404 0.004 126.890 0.004
202407 -0.001 128.075 -0.001
202410 0.016 127.838 0.016
202501 0.010 127.443 0.010
202504 0.006 129.102 0.006
202507 0.002 130.290 0.002
202510 0.000 130.600 0.000
202601 -0.001 130.370 -0.001

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
Sona Nanotech (SNANF) has a Cyclically Adjusted Book per Share of $0.00 as of Jan. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sona Nanotech and its competitors.
Is Sona Nanotech's Cyclically Adjusted Book per Share too high?
Sona Nanotech's current Cyclically Adjusted Book per Share is $0.00. Overall, Sona Nanotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Sona Nanotech's Cyclically Adjusted Book per Share compare to TMO and DHR?
Sona Nanotech's Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sona Nanotech and its competitors. Sona Nanotech's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sona Nanotech stock overvalued right now?
Sona Nanotech (SNANF) has a current Cyclically Adjusted Book per Share of $0.00. The current Cyclically Adjusted Book per Share is $0.00. Sona Nanotech's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sona Nanotech (SNANF), the current Cyclically Adjusted Book per Share is $0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sona Nanotech Business Description

Other Exchanges SONA:Canada
Address 1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc is involved in the nanotechnology life sciences industry. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles and is engaged in the research and development of its proprietary technology for use in biomedical applications and multiplex diagnostic testing platforms. The company is using its gold nano rods manufacturing technology to develop new products and methods for cancer treatment, including a Targeted Hyperthermia Therapy (THT). Additionally, it has filed patent applications in the U.S. regarding a gold nanorod conjugation concept for targeted drug delivery, combination therapies for treating cancer, and for an endoscope with an optical fibre and thermal sensor for photothermal therapy.
26GF Score

Get the complete analysis for SNANF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price